Literature DB >> 18656960

Chemical mechanism of a cysteine protease, cathepsin C, as revealed by integration of both steady-state and pre-steady-state solvent kinetic isotope effects.

Jessica L Schneck1, James P Villa, Patrick McDevitt, Michael S McQueney, Sara H Thrall, Thomas D Meek.   

Abstract

Cathepsin C, or dipeptidyl peptidase I, is a lysosomal cysteine protease of the papain family that catalyzes the sequential removal of dipeptides from the free N-termini of proteins and peptides. Using the dipeptide substrate Ser-Tyr-AMC, cathepsin C was characterized in both steady-state and pre-steady-state kinetic modes. The pH(D) rate profiles for both log k cat/ K m and log k cat conformed to bell-shaped curves for which an inverse solvent kinetic isotope effect (sKIE) of 0.71 +/- 0.14 for (D)( k cat/ K a) and a normal sKIE of 2.76 +/- 0.03 for (D) k cat were obtained. Pre-steady-state kinetics exhibited a single-exponential burst of AMC formation in which the maximal acylation rate ( k ac = 397 +/- 5 s (-1)) was found to be nearly 30-fold greater than the rate-limiting deacylation rate ( k dac = 13.95 +/- 0.013 s (-1)) and turnover number ( k cat = 13.92 +/- 0.001 s (-1)). Analysis of pre-steady-state burst kinetics in D 2O allowed abstraction of a normal sKIE for the acylation half-reaction that was not observed in steady-state kinetics. Since normal sKIEs were obtained for all measurable acylation steps in the presteady state [ (D) k ac = 1.31 +/- 0.04, and the transient kinetic isotope effect at time zero (tKIE (0)) = 2.3 +/- 0.2], the kinetic step(s) contributing to the inverse sKIE of (D)( k cat/ K a) must occur more rapidly than the experimental time frame of the transient kinetics. Results are consistent with a chemical mechanism in which acylation occurs via a two-step process: the thiolate form of Cys-234, which is enriched in D 2O and gives rise to the inverse value of (D)( k cat/ K a), attacks the substrate to form a tetrahedral intermediate that proceeds to form an acyl-enzyme intermediate during a proton transfer step expressing a normal sKIE. The subsequent deacylation half-reaction is rate-limiting, with proton transfers exhibiting normal sKIEs. Through derivation of 12 equations describing all kinetic parameters and sKIEs for the proposed cathepsin C mechanism, integration of both steady-state and pre-steady-state kinetics with sKIEs allowed the provision of at least one self-consistent set of values for all 13 rate constants in this cysteine protease's chemical mechanism. Simulation of the resulting kinetic profile showed that at steady state approximately 80% of the enzyme exists in an active-site cysteine-acylated form in the mechanistic pathway. The chemical and kinetic details deduced from this work provide a potential roadmap to help steer drug discovery efforts for this and other disease-relevant cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656960     DOI: 10.1021/bi8007627

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

Review 1.  New approaches for dissecting protease functions to improve probe development and drug discovery.

Authors:  Edgar Deu; Martijn Verdoes; Matthew Bogyo
Journal:  Nat Struct Mol Biol       Date:  2012-01-05       Impact factor: 15.369

Review 2.  Mechanistic enzymology in drug discovery: a fresh perspective.

Authors:  Geoffrey A Holdgate; Thomas D Meek; Rachel L Grimley
Journal:  Nat Rev Drug Discov       Date:  2017-12-01       Impact factor: 84.694

3.  Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1.

Authors:  Flora Wang; Priscilla Krai; Edgar Deu; Brittney Bibb; Conni Lauritzen; John Pedersen; Matthew Bogyo; Michael Klemba
Journal:  Mol Biochem Parasitol       Date:  2010-09-15       Impact factor: 1.759

4.  Transient kinetic analysis of USP2-catalyzed deubiquitination reveals a conformational rearrangement in the K48-linked diubiquitin substrate.

Authors:  William P Bozza; Qin Liang; Ping Gong; Zhihao Zhuang
Journal:  Biochemistry       Date:  2012-12-04       Impact factor: 3.162

5.  Kinetic and structural investigations of the allosteric site in human epithelial 15-lipoxygenase-2.

Authors:  Aaron T Wecksler; Victor Kenyon; Natalie K Garcia; Joshua D Deschamps; Wilfred A van der Donk; Theodore R Holman
Journal:  Biochemistry       Date:  2009-09-15       Impact factor: 3.162

6.  Mechanism of action of thalassospiramides, a new class of calpain inhibitors.

Authors:  Liang Lu; Michael J Meehan; Shuo Gu; Zhilong Chen; Weipeng Zhang; Gen Zhang; Lingli Liu; Xuhui Huang; Pieter C Dorrestein; Ying Xu; Bradley S Moore; Pei-Yuan Qian
Journal:  Sci Rep       Date:  2015-03-05       Impact factor: 4.379

7.  Allosteric Tuning of Caspase-7: A Fragment-Based Drug Discovery Approach.

Authors:  Nicholas R Vance; Lokesh Gakhar; M Ashley Spies
Journal:  Angew Chem Int Ed Engl       Date:  2017-10-09       Impact factor: 15.336

Review 8.  Inverse Solvent Isotope Effects in Enzyme-Catalyzed Reactions.

Authors:  Patrick L Fernandez; Andrew S Murkin
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

9.  Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6.

Authors:  Christopher E Heise; Jeremy Murray; Katherine E Augustyn; Brandon Bravo; Preeti Chugha; Frederick Cohen; Anthony M Giannetti; Paul Gibbons; Rami N Hannoush; Brian R Hearn; Priyadarshini Jaishankar; Cuong Q Ly; Kinjalkumar Shah; Karen Stanger; Micah Steffek; Yinyan Tang; Xianrui Zhao; Joseph W Lewcock; Adam R Renslo; John Flygare; Michelle R Arkin
Journal:  PLoS One       Date:  2012-12-05       Impact factor: 3.240

10.  Heparin modulates the endopeptidase activity of Leishmania mexicana cysteine protease cathepsin L-Like rCPB2.8.

Authors:  Wagner A S Judice; Marcella A Manfredi; Gerson P Souza; Thiago M Sansevero; Paulo C Almeida; Cláudio S Shida; Tarsis F Gesteira; Luiz Juliano; Gareth D Westrop; Sanya J Sanderson; Graham H Coombs; Ivarne L S Tersariol
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.